Alprolix®

Active substance

 Eftrenacog alfa

Holder

 Sobi Belgium

Status

Closed

Indication

 Treatment and prophylaxis of bleedings in hemophilia B patients (deficiency= Factor IX coagulation factor)

Public documents

Approbation

Information for the patient

Informed consent

Last update

17/01/2018
Last updated on